Could ASEAN Become Next Priority For Korean Pharma Firms?

Challenging But There Are Opportunities

 
• By Jung Won Shin
Yongho Yi, LSHC Insight Lead, Deloitte
Tech-based meds a Promising Initial Option for korean firms in SE Asia? • Source: KIMCo

More from Business

More from Scrip